Ilyang Pharmaceutical CEO Yuseok Jeong to Receive 1.7 Million Shares as Gift, Increasing Stake from 4.14% to 12.84%
Ilyang Pharmaceutical CEO Yuseok Jeong has reported a plan to receive 1,700,000 common shares as a gift from Jeong Do-eon on July 30, 2026.
After the gift, his total holdings will increase to 2,508,777 shares, raising his stake from 4.14% to 12.84%.
This transaction is a private gift between controlling shareholders, not a capital market fundraising, and does not dilute existing shareholders.
[AI Summary]The largest shareholder's stake has increased by 8.7 percentage points, strengthening management control. Since this involves a transfer of existing shares rather than a new issuance, there is no dilution risk to shareholder value, but the increased control of the owner family may impact minority shareholder rights.
KOSPI Filing Information
Report On Transaction Plan Of Specific Securities By Executives And Major Shareholders